SARS‐CoV ‐2 antibody persistence in COVID ‐19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

(2021) Jennifer M. Dan et al.   SCIENCE

Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic

(2021) Lewis F. Buss et al.   SCIENCE

Selecting COVID ‐19 convalescent plasma for neutralizing antibody potency using a high‐capacity SARS‐CoV ‐2 antibody assay

(2021) Erin Goodhue Meyer et al.   TRANSFUSION

A SARS-CoV-2 Label-Free Surrogate Virus Neutralization Test and a Longitudinal Study of Antibody Characteristics in COVID-19 Patients

(2021) Yiqi Ruben Luo et al.   JOURNAL OF CLINICAL MICROBIOLOGY

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection

(2020) Paul Kellam et al.   JOURNAL OF GENERAL VIROLOGY

Antibody responses to SARS-CoV-2 in patients with COVID-19

(2020) Quan-Xin Long et al.   NATURE MEDICINE

Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York

(2020) Eli S. Rosenberg et al.   ANNALS OF EPIDEMIOLOGY

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

(2020) Quan-Xin Long et al.   NATURE MEDICINE

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

(2020) F. Javier Ibarrondo et al.   NEW ENGLAND JOURNAL OF MEDICINE

An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment

(2020) Corine H. GeurtsvanKessel et al.   Nature Communications

Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020

(2020) Fiona P. Havers et al.   JAMA Internal Medicine

Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Avidity Maturation and Association with Disease Severity

(2020) Yiqi Ruben Luo et al.   CLINICAL INFECTIOUS DISEASES

Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee

(2020) Manish M. Patel et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors

(2020) Sarah E Benner et al.   JOURNAL OF INFECTIOUS DISEASES

SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood

(2020) Dianna L. Ng et al.   Nature Communications

Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset

(2020) Josée Perreault et al.   BLOOD

Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity

(2020) Hejun Liu et al.   IMMUNITY

Convalescent plasma anti–SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization

(2020) Eric Salazar et al.   JOURNAL OF CLINICAL INVESTIGATION

The Importance and Challenges of Identifying SARS-CoV-2 Reinfections

(2020) Ahmed Babiker et al.   JOURNAL OF CLINICAL MICROBIOLOGY

SARS-CoV-2 Serologic Assay Needs for the Next Phase of the US COVID-19 Pandemic Response

(2020) Adi V Gundlapalli et al.   Open Forum Infectious Diseases

Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19

(2020) Carlo Cervia et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY